Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.0K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

3.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Lateralization01:28

Lateralization

1.1K
Brain lateralization refers to the division of mental processes and functions between the two hemispheres of the brain, a phenomenon that optimizes neural efficiency and underpins complex abilities in humans. This specialization allows each hemisphere to perform tasks where it has a comparative advantage, facilitating more refined cognitive capabilities across different domains.
1.1K
Cranial Bones: Lateral View01:27

Cranial Bones: Lateral View

4.5K
The lateral view of the cranium is dominated by temporal, sphenoid, and ethmoid bones.
The temporal bone forms the lower lateral side of the skull. The temporal bone is subdivided into several regions. The flattened upper portion is the squamous portion of the temporal bone. Below this area and projecting anteriorly is the zygomatic process of the temporal bone, which forms the posterior portion of the zygomatic arch. Posteriorly is the mastoid portion of the temporal bone. Projecting...
4.5K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treating skin and soft tissue infections.

JAAPA : official journal of the American Academy of Physician Assistants·2016
Same author

An interactive electronic instructional unit on substance abuse.

Journal of allied health·2009
Same author

Pharmacoepidemiology of potential alcohol-prescription drug interactions among primary care patients with alcohol-use disorders.

Journal of the American Pharmacists Association : JAPhA·2007
Same author

Community-based substance abuse training: helping children living in families with substance-abusing adults.

Substance abuse·2006
Same author

Efficacy of zinc against common cold viruses: an overview.

Journal of the American Pharmacists Association : JAPhA·2004
Same author

The burden of illness of irritable bowel syndrome: current challenges and hope for the future.

Journal of managed care pharmacy : JMCP·2004

Related Experiment Video

Updated: Feb 5, 2026

Evaluation of Motor Impairment in C. elegans Models of Amyotrophic Lateral Sclerosis
08:27

Evaluation of Motor Impairment in C. elegans Models of Amyotrophic Lateral Sclerosis

Published on: September 2, 2021

4.8K

Amyotrophic lateral sclerosis: disease state overview.

Darrell Hulisz1

  • 1Associate Professor, Department of Family Medicine, Case Western Reserve University School of Medicine; Clinical Pharmacy Specialist, University Hospitals Medical Group, Cleveland, OH.

The American Journal of Managed Care
|September 13, 2018
PubMed
Summary

Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease affecting 16,000 individuals, leading to paralysis. Research in ALS patient registries has identified key biomarkers and genes, improving management strategies.

More Related Videos

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.7K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.7K

Related Experiment Videos

Last Updated: Feb 5, 2026

Evaluation of Motor Impairment in C. elegans Models of Amyotrophic Lateral Sclerosis
08:27

Evaluation of Motor Impairment in C. elegans Models of Amyotrophic Lateral Sclerosis

Published on: September 2, 2021

4.8K
Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis
07:00

Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis

Published on: October 13, 2016

8.7K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.7K

Area of Science:

  • Neurology
  • Genetics
  • Epidemiology

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
  • It leads to motor neuron loss in the brain and spinal cord, resulting in paralysis.
  • ALS impacts approximately 16,000 people, with a survival prognosis of 2-5 years.

Purpose of the Study:

  • To summarize the current understanding of Amyotrophic Lateral Sclerosis (ALS).
  • To highlight diagnostic methods and genetic classifications.
  • To emphasize the importance of patient registries in discovering ALS biomarkers and genes.

Main Methods:

  • Diagnosis involves excluding other conditions.
  • Utilizes clinical examinations, laboratory tests, and electrophysiological studies.
  • Information gathered from ALS patient registries aids in discovery.

Main Results:

  • Two genetic types of ALS exist: familial and sporadic.
  • Patient registries have facilitated the discovery of ALS-associated biomarkers and genes.
  • An interdisciplinary approach is crucial for ALS management.

Conclusions:

  • Effective ALS management requires a comprehensive, interdisciplinary approach.
  • Understanding genetic factors and utilizing patient data are key to advancing ALS research.
  • Addressing the holistic needs of patients and their families is paramount.